104 related articles for article (PubMed ID: 29105934)
1. Toward a Novel Drug To Target the EGF-EGFR Interaction: Design of Metabolically Stable Bicyclic Peptides.
Guardiola S; Seco J; Varese M; Díaz-Lobo M; García J; Teixidó M; Nevola L; Giralt E
Chembiochem; 2018 Jan; 19(1):76-84. PubMed ID: 29105934
[TBL] [Abstract][Full Text] [Related]
2. Comparative experimental/theoretical studies on the EGFR dimerization under the effect of EGF/EGF analogues binding: Highlighting the importance of EGF/EGFR interactions at site III interface.
Mehrabi M; Mahdiuni H; Rasouli H; Mansouri K; Shahlaei M; Khodarahmi R
Int J Biol Macromol; 2018 Aug; 115():401-417. PubMed ID: 29665393
[TBL] [Abstract][Full Text] [Related]
3. Peptides Targeting EGF Block the EGF-EGFR Interaction.
Guardiola S; Díaz-Lobo M; Seco J; García J; Nevola L; Giralt E
Chembiochem; 2016 Apr; 17(8):702-11. PubMed ID: 26677067
[TBL] [Abstract][Full Text] [Related]
4. Role of N-glycosylation in EGFR ectodomain ligand binding.
Azimzadeh Irani M; Kannan S; Verma C
Proteins; 2017 Aug; 85(8):1529-1549. PubMed ID: 28486782
[TBL] [Abstract][Full Text] [Related]
5. Tenascin cytotactin epidermal growth factor-like repeat binds epidermal growth factor receptor with low affinity.
Iyer AK; Tran KT; Borysenko CW; Cascio M; Camacho CJ; Blair HC; Bahar I; Wells A
J Cell Physiol; 2007 Jun; 211(3):748-58. PubMed ID: 17311283
[TBL] [Abstract][Full Text] [Related]
6. Docking and molecular dynamics simulation study of EGFR1 with EGF-like peptides to understand molecular interactions.
Sudhakar DR; P K; Subbarao N
Mol Biosyst; 2016 May; 12(6):1987-95. PubMed ID: 27072492
[TBL] [Abstract][Full Text] [Related]
7. Protein-protein interactions between SWCNT/chitosan/EGF and EGF receptor: a model of drug delivery system.
Rungnim C; Rungrotmongkol T; Kungwan N; Hannongbua S
J Biomol Struct Dyn; 2016 Sep; 34(9):1919-29. PubMed ID: 26381241
[TBL] [Abstract][Full Text] [Related]
8. Critical effects on binding of epidermal growth factor produced by amino acid substitutions.
Mehrabi M; Khodarahmi R; Shahlaei M
J Biomol Struct Dyn; 2017 Apr; 35(5):1085-1101. PubMed ID: 27212100
[TBL] [Abstract][Full Text] [Related]
9. Protein Chemical Synthesis Combined with Mirror-Image Phage Display Yields d-Peptide EGF Ligands that Block the EGF-EGFR Interaction.
Díaz-Perlas C; Varese M; Guardiola S; Sánchez-Navarro M; García J; Teixidó M; Giralt E
Chembiochem; 2019 Aug; 20(16):2079-2084. PubMed ID: 31268623
[TBL] [Abstract][Full Text] [Related]
10. Shedding of epidermal growth factor receptor is a regulated process that occurs with overexpression in malignant cells.
Perez-Torres M; Valle BL; Maihle NJ; Negron-Vega L; Nieves-Alicea R; Cora EM
Exp Cell Res; 2008 Oct; 314(16):2907-18. PubMed ID: 18687326
[TBL] [Abstract][Full Text] [Related]
11. Peptide ligands for targeting the extracellular domain of EGFR: Comparison between linear and cyclic peptides.
Williams TM; Sable R; Singh S; Vicente MGH; Jois SD
Chem Biol Drug Des; 2018 Feb; 91(2):605-619. PubMed ID: 29052959
[TBL] [Abstract][Full Text] [Related]
12. Quantitative analysis of ligand-EGFR interactions: a platform for screening targeting molecules.
Kuo WT; Lin WC; Chang KC; Huang JY; Yen KC; Young IC; Sun YJ; Lin FH
PLoS One; 2015; 10(2):e0116610. PubMed ID: 25723471
[TBL] [Abstract][Full Text] [Related]
13. Activation of the epidermal growth factor receptor: a series of twists and turns.
Poger D; Mark AE
Biochemistry; 2014 Apr; 53(16):2710-21. PubMed ID: 24697572
[TBL] [Abstract][Full Text] [Related]
14. EGF signalling amplification induced by dynamic clustering of EGFR.
Ichinose J; Murata M; Yanagida T; Sako Y
Biochem Biophys Res Commun; 2004 Nov; 324(3):1143-9. PubMed ID: 15485674
[TBL] [Abstract][Full Text] [Related]
15. Compounds identified by virtual docking to a tetrameric EGFR extracellular domain can modulate Grb2 internalization.
Ramirez UD; Nikonova AS; Liu H; Pecherskaya A; Lawrence SH; Serebriiskii IG; Zhou Y; Robinson MK; Einarson MB; Golemis EA; Jaffe EK
BMC Cancer; 2015 May; 15():436. PubMed ID: 26016476
[TBL] [Abstract][Full Text] [Related]
16. Development of a human epidermal growth factor derivative with EGFR-blocking and depleted biological activities: A comparative in vitro study using EGFR-positive breast cancer cells.
Mehrabi M; Mansouri K; Soleymani B; Hoseinkhani Z; Shahlaie M; Khodarahmi R
Int J Biol Macromol; 2017 Oct; 103():275-285. PubMed ID: 28501600
[TBL] [Abstract][Full Text] [Related]
17. NMR structure and backbone dynamics of a concatemer of epidermal growth factor homology modules of the human low-density lipoprotein receptor.
Kurniawan ND; Aliabadizadeh K; Brereton IM; Kroon PA; Smith R
J Mol Biol; 2001 Aug; 311(2):341-56. PubMed ID: 11478865
[TBL] [Abstract][Full Text] [Related]
18. Growth hormone alters epidermal growth factor receptor binding affinity via activation of extracellular signal-regulated kinases in 3T3-F442A cells.
Huang Y; Chang Y; Wang X; Jiang J; Frank SJ
Endocrinology; 2004 Jul; 145(7):3297-306. PubMed ID: 15070853
[TBL] [Abstract][Full Text] [Related]
19. The membrane-anchoring domain of epidermal growth factor receptor ligands dictates their ability to operate in juxtacrine mode.
Dong J; Opresko LK; Chrisler W; Orr G; Quesenberry RD; Lauffenburger DA; Wiley HS
Mol Biol Cell; 2005 Jun; 16(6):2984-98. PubMed ID: 15829568
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of dimerization-inhibitory activities of cyclic peptides containing a β-hairpin loop sequence of the EGF receptor.
Mizuguchi T; Ohara N; Iida M; Ninomiya R; Wada S; Kiso Y; Saito K; Akaji K
Bioorg Med Chem; 2012 Oct; 20(19):5730-7. PubMed ID: 22959765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
